The global vascular closure devices market size reached USD 1.56 Billion in 2024. Looking forward, the market is projected to reach USD 2.40 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. Increasing prevalence of cardiovascular disease (CVDs), rising vascular procedures, technological advancements in closure devices, aging population demographics favoring minimally invasive (MI) treatments, regulatory support, strategic industry initiatives, expanding healthcare expenditure in emerging markets, challenges in device approval, and ongoing innovation efforts are some of the factors stimulating the market expansion.
Vascular closure devices (VCDs) are used in hospitals, clinics, and specialty and ambulatory surgery centers across the globe to immediately seal the small puncture made in an artery after an angiogram. These devices are widely utilized among patients undergoing catheterization via the femoral route as compared to traditional mechanical compression. They assist in reducing the risk of immediate bleeding from the groin puncture site. Besides this, they also aid in setting a large body habitus and anticoagulation and antiplatelet therapies. As they offer various benefits, such as reducing the time to hemostasis, facilitating patient mobilization, lowering patient discomfort associated with prolonged bed rest, decreasing hospital stays, and preventing femoral artery complications, the demand for VCDs is increasing worldwide.
Vascular closure devices (VCDs) are used in hospitals, clinics, and specialty and ambulatory surgery centers across the globe to immediately seal the small puncture made in an artery after an angiogram. These devices are widely utilized among patients undergoing catheterization via the femoral route as compared to traditional mechanical compression. They assist in reducing the risk of immediate bleeding from the groin puncture site. Besides this, they also aid in setting a large body habitus and anticoagulation and antiplatelet therapies. As they offer various benefits, such as reducing the time to hemostasis, facilitating patient mobilization, lowering patient discomfort associated with prolonged bed rest, decreasing hospital stays, and preventing femoral artery complications, the demand for VCDs is increasing worldwide.
Vascular Closure Devices Market Trends:
At present, there is a rise in the prevalence of cardiovascular diseases (CVDs), such as stroke and coronary heart, peripheral arterial, and aortic diseases, across the globe. This, along with the burgeoning healthcare industry, represents one of the key factors supporting the growth of the market. Besides this, the escalating demand for catheterization and interventional procedures for diagnosing and treating CVDs is offering lucrative growth opportunities to industry investors. In addition, the growing demand for advanced surgical equipment in hospitals and surgical centers is positively influencing the market. Moreover, there is an increase in the demand for femoral mode for vascular access during coronary angiography and other interventional procedures around the world. This, coupled with the growing demand for non-invasive procedures to avoid stitches and scarring, is positively influencing the market. Apart from this, the rising focus of doctors on effective blood loss management in patients during surgical procedures is strengthening the growth of the market. Additionally, key manufacturers operating in the industry are focusing on manufacturing large-bore vascular closure devices. In line with this, the increasing number of registrations for innovative devices by key market players is propelling the growth of the market. Furthermore, the rising awareness among the masses about the benefits of VCDs, such as enabling minimal invasions, high patient outcomes, early ambulation, and comfort during procedures, is bolstering the growth of the market.Key Market Segmentation:
This report provides an analysis of the key trends in each segment of the global vascular closure devices market report, along with forecasts at the global, regional and country level from 2025-2033. The report has categorized the market based on product, access, procedure, and end-user.Product Insights:
- Passive Approximators
- Collagen Plugs
- Sealant or Gel-Based Devices
- Compression-Assist Devices
- Active Approximators
- Suture-Based Devices
- Clip-Based Devices
- External Hemostatic Devices
Access Insights:
- Femoral Access
- Radial Access
Procedure Insights:
- Interventional Cardiology
- Interventional Radiology/Vascular Surgery
End-User Insights:
- Hospitals
- Ambulatory Surgical Centers
- Others
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global vascular closure devices market. Detailed profiles of all major companies have also been provided. Some of the companies include Abbott Laboratories, Cardiva Medical Inc. (Haemonetics Corporation), Cordis Corporation (Cardinal Health Inc.), ENDOCOR GmbH & Co. KG, Merit Medical Systems Inc., Morris Innovative Inc., Teleflex Incorporated, Terumo Medical Corporation (Terumo Corporation), Transluminal Technologies LLC, Vasorum Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.Key Questions Answered in This Report:
- - How has the global acetone market performed so far and how will it perform in the coming years?
- - What are the drivers, restraints, and opportunities in the global acetone market?
- - What are the key regional markets?
- - Which countries represent the most attractive acetone markets?
- - What is the breakup of the market based on the application?
- - What is the breakup of the market based on the grade?
- - What is the breakup of the market based on the distribution channel?
- - What is the breakup of the market based on the end use industry?
- - What is the competitive structure of the global acetone market?
- - Who are the key players/companies in the global acetone market?
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis14 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Vascular Closure Devices Market
6 Market Breakup by Product
7 Market Breakup by Access
8 Market Breakup by Procedure
9 Market Breakup by End-User
10 Market Breakup by Region
11 Drivers, Restraints, and Opportunities
13 Porters Five Forces Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- Cardiva Medical Inc. (Haemonetics Corporation)
- Cordis Corporation (Cardinal Health Inc.)
- ENDOCOR GmbH & Co. KG
- Merit Medical Systems Inc.
- Morris Innovative Inc.
- Teleflex Incorporated
- Terumo Medical Corporation (Terumo Corporation)
- Transluminal Technologies LLC
- Vasorum Ltd.
